Physicians' Opinions About Responsibility for Patient Out-of-Pocket Costs and Formulary Prescribing in Two Midwestern States
暂无分享,去创建一个
Shamima Khan | Robert Sylvester | D. Scott | David Scott | Bruce Pitts | B. Pitts | Robert A. Sylvester | Shamima Khan
[1] B. Motheral,et al. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. , 1999, The American journal of managed care.
[2] K. Fairman. The Future of Prescription Drug Cost-Sharing: Real Progress or Dropped Opportunity? , 2008, Journal of managed care pharmacy : JMCP.
[3] K. Farris,et al. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services part 1. , 2002, Journal of managed care pharmacy : JMCP.
[4] J. Avorn. Balancing the cost and value of medications: the dilemma facing clinicians. , 2002, PharmacoEconomics.
[5] B. Dowd,et al. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. , 2007, Journal of managed care pharmacy : JMCP.
[6] Dana P Goldman,et al. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. , 2006, The American journal of managed care.
[7] Thomas Pasko,et al. Physician Characteristics and Distribution in the Us: 1999 , 1998 .
[8] MS Dr. G. Caleb Alexander MD,et al. Barriers to patient-physician communication about out-of-pocket costs , 2007, Journal of general internal medicine.
[9] B. Motheral,et al. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. , 2003, Clinical therapeutics.
[10] Todd D. Sorensen,et al. Assessing risk for loss of rural pharmacy services in Minnesota. , 2005, Journal of the American Pharmacists Association : JAPhA.
[11] Howard C. Anderson,et al. The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities , 2004 .
[12] B. Motheral,et al. Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization , 2001, Medical care.
[13] K. Knapp,et al. Availability of primary care providers and pharmacists in the United States. , 1999, Journal of the American Pharmaceutical Association.
[14] T. Rector,et al. Exhaustion of drug benefits and disenrollment of medicare beneficiaries from managed care organizations. , 2000, JAMA.
[15] L. Casalino,et al. Patient-physician communication about out-of-pocket costs. , 2003, JAMA.
[16] D. Taira,et al. Alternate Financial Incentives in Multi-tiered Formulary Systems to Improve Accountability for Outcomes , 2003, Journal of managed care pharmacy : JMCP.
[17] David O Meltzer,et al. Physician strategies to reduce patients' out-of-pocket prescription costs. , 2005, Archives of internal medicine.
[18] R. Epstein,et al. The effect of incentive-based formularies on prescription-drug utilization and spending. , 2003, The New England journal of medicine.
[19] K. Covinsky,et al. Self-restriction of medications due to cost in seniors without prescription coverage , 2001, Journal of General Internal Medicine.
[20] R. Kravitz,et al. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? , 2006, The American journal of managed care.
[21] Steven M. Asch,et al. The effect of pharmacy benefit design on patient-physician communication about costs , 2006, Journal of General Internal Medicine.
[22] R. Kravitz,et al. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. , 2005, The American journal of managed care.
[23] Susan L Ettner,et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. , 2006, Archives of internal medicine.
[24] R. Kravitz,et al. Physicians’ Perceived Knowledge of and Responsibility for Managing Patients’ Out-of-Pocket Costs for Prescription Drugs , 2006, The Annals of pharmacotherapy.